Premium
Use of Apremilast in Patients With Psoriatic Arthritis During the COVID‐19 Pandemic: Comment on the Article by Mikuls et al
Author(s) -
Bansal Pankaj,
Goyal Amandeep,
Cusick Austin,
Aslam Fawad
Publication year - 2021
Publication title -
arthritis and rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.106
H-Index - 314
eISSN - 2326-5205
pISSN - 2326-5191
DOI - 10.1002/art.41575
Subject(s) - apremilast , medicine , psoriatic arthritis , adverse effect , rheumatology , infliximab , intensive care medicine , dermatology , disease